Aggregated Patient-Reported Outcomes After Non-Invasive Vision Restoration Therapy for Retinal and Optic Nerve Disorders: A Single-Center Survey Dataset from Fedorov Restore Vision Clinic, 2018–2021 (n=626)

This dataset provides the aggregated clinical summary statistics derived from 626 patient follow-up survey responses. These patients were treated with repetitive transorbital alternating current stimulation (rtACS) at the Fedorov Restore Vision Clinic (Berlin, Germany) between October 2018 and October 2021. The aggregated statistics quantify treatment satisfaction, functional visual outcomes, and quality-of-life impacts across diverse pre-chiasmatic visual pathway pathologies, including peripheral vision loss, blurred/hazy vision, night blindness, and central vision loss. The primary outcomes include an overall combined positive satisfaction rate of 87.9% and detailed satisfaction distributions organized by condition category. DATA AVAILABILITY STATEMENT (RESTRICTED RAW DATA ACCESS) The open-access CC BY 4.0 license applies strictly and exclusively to the published Aggregated Summary Statistics and the Data Dictionary documentation provided in this repository. The underlying anonymized, raw patient-level visual field data, visual acuity metrics, and free-text survey responses (the 626-row database) are restricted from public disclosure to ensure strict compliance with European patient privacy regulations (GDPR), research ethics, and institutional data protection policies. The verified clinical raw data can be technically provided to independent medical researchers or academic institutions by the corresponding author (Dr. Anton Fedorov) upon reasonable and verified professional request. Any granted access explicitly prohibits attempts to re-identify patients or publish derivative commercial analyses.本数据集源自2018年10月至2021年10月期间，在德国柏林费多罗夫视力恢复诊所（Fedorov Restore Vision Clinic）接受重复性经眶交流电刺激（repetitive transorbital alternating current stimulation, rtACS）治疗的626名患者的随访问卷汇总临床统计数据。 该汇总统计数据量化了针对多种视交叉前视觉通路病变（包括周边视野缺损、视物模糊/雾视、夜盲及中心视野缺损）患者的治疗满意度、功能性视觉结局及生活质量影响。主要结局指标包括总体综合阳性满意度率87.9%，以及按病症类别划分的细分满意度分布情况。 数据可用性声明（受限原始数据访问） 本仓库中发布的汇总统计数据及数据字典文档，严格且仅适用知识共享署名4.0（CC BY 4.0）许可协议。 本研究的匿名化患者层面原始视野数据、视力指标及自由文本随访问卷回复（即含626条记录的数据库），因需严格遵守欧盟患者隐私法规（通用数据保护条例，General Data Protection Regulation, GDPR）、研究伦理及机构数据保护政策，无法公开获取。经核实的临床原始数据可应独立医学研究者或学术机构的合理且经核实的专业申请，由通讯作者安东·费多罗夫博士（Dr. Anton Fedorov）提供。任何获批的访问权限均明确禁止重新识别患者身份或发布衍生性商业分析成果。